Sun Pharma Advanced Research Company Ltd.
Records under this name other than the patents Sun Pharma Advanced Research Company Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
Back to Sun Pharma Advanced Research Company Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,413,543 | Stable Multiparticulate Pharmaceutical Composition of Rosuvastatin Formerly held In force · High confidence | In force | High confidence | |
| US 11,465,990 | Novel Heterocyclic Antiestrogens Lapsed on the fee record Ended Oct 11, 2026 · High confidence | Lapsed on the fee record | Ended Oct 11, 2026 | High confidence |
| US 11,439,600 | Abuse Deterrent Oral Solid Dosage Form Lapsed on the fee record Ended Sep 13, 2026 · High confidence | Lapsed on the fee record | Ended Sep 13, 2026 | High confidence |
| US 10,213,387 | Oral Drug Delivery System Term ended Ended no later than Sep 6, 2026 · Low confidence | Term ended | Ended no later than Sep 6, 2026 | Low confidence |
| US 8,778,364 | Nanodispersion of a Drug and Process for Its Preparation Lapsed on the fee record Ended Jul 15, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 15, 2026 | Medium confidence |
| US 9,980,917 | Abuse deterrent immediate release coated reservoir solid dosage form Lapsed on the fee record Ended May 29, 2026 · USPTO record | Lapsed on the fee record | Ended May 29, 2026 | USPTO record |
| US 11,304,898 | Method of treating carcinoma Lapsed on the fee record Ended Apr 19, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 19, 2026 | USPTO record |
| US 11,273,126 | Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N′-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide Lapsed on the fee record Ended Mar 15, 2026 · USPTO record | Lapsed on the fee record | Ended Mar 15, 2026 | USPTO record |
| US 8,425,938 | Pharmaceutical composition Term ended Ended no later than Feb 22, 2026 · USPTO record | Term ended | Ended no later than Feb 22, 2026 | USPTO record |
| US 8,535,717 | Pharmaceutical composition Term ended Ended no later than Feb 22, 2026 · USPTO record | Term ended | Ended no later than Feb 22, 2026 | USPTO record |